AMRZ.SW stock trades at CHF45.04 intraday on 16 Feb 2026 as investors position ahead of an earnings report scheduled for 17 Feb 2026. The market is watching margins and North American building-materials volumes after Amrize AG separated from Holcim. Intraday range is CHF44.40 to CHF45.10, volume at 181,825 shares, and the stock sits near its 50-day average of CHF43.47.
AMRZ.SW stock: earnings preview and calendar
Amrize AG (AMRZ.SW) reports results on 17 Feb 2026. Analysts expect commentary on North American cement and aggregates demand and margin recovery following the June 2025 separation from Holcim. Management guidance will likely move the stock; a positive margin surprise could push the price above the year high CHF46.76, while weak guidance would test the year low CHF35.20.
Advertisement
Valuation and financial metrics for AMRZ.SW stock
At CHF45.04, Amrize shows a trailing PE of 24.67 and EPS of 1.83. Market cap is CHF24,966,124,595, with 553,082,069 shares outstanding. The price sits above the 50-day average CHF43.47 and 200-day average CHF41.20, signalling recent strength versus longer-term trend.
AMRZ.SW stock technicals and intraday action
Momentum indicators show a neutral-to-positive setup. RSI is 58.59, MACD is 0.85 with a histogram at -0.08, and ATR is 0.94. Bollinger Bands run CHF41.45 to CHF45.40, so intraday volatility is contained. Relative volume is 0.51, meaning trading is lighter than average, which could amplify post-earnings moves.
Meyka AI rates AMRZ.SW with a score out of 100
Meyka AI rates AMRZ.SW with a score out of 100. Score: 61.52 out of 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI, an AI-powered market analysis platform, uses this composite to show relative strength and risk. These grades are informational only and not financial advice.
AMRZ.SW stock catalysts, sector context and risks
Key catalysts before and after earnings include North American pricing, input-cost trends, and any guidance on capital allocation. Amrize sits in the Basic Materials sector, where average PE is 20.19; AMRZ’s PE of 24.67 reflects a premium on growth expectations. Main risks are volume declines, margin pressure, and liquidity when average volume is 2,150,647 compared with today’s 181,825.
AMRZ.SW stock outlook and trading note
Traders should watch immediate support at CHF44.40 and resistance at CHF45.10 intraday. A post-earnings gap beyond CHF46.76 would signal renewed upside. Use tight stops and size positions relative to volatility, given on‑hand average daily volume is higher than today’s trade. For more background see Amrize’s company page at Amrize at Holcim and our stock hub at Meyka AMRZ.SW page.
Final Thoughts
Meyka AI’s forecast model projects a yearly target of CHF48.24, implying an upside of 7.11% from the current CHF45.04 price. Shorter term, the monthly projection is CHF44.15, implying a slight downside of -1.98% ahead of the earnings print. Given a PE of 24.67 versus the Basic Materials average 20.19, Amrize trades at a modest premium tied to its North American exposure. Our grade is B (61.52/100) and suggests a HOLD stance into results. Forecasts are model-based projections and not guarantees, and earnings outcomes on 17 Feb 2026 will be the immediate driver of volatility and directional trade opportunities
Advertisement
FAQs
When does Amrize report earnings and how could that affect AMRZ.SW stock?
Amrize is scheduled to report on 17 Feb 2026. Earnings may move AMRZ.SW stock sharply if management updates North American volume or margin guidance; expect higher intraday volatility and potential gaps beyond CHF46.76 or below CHF35.20.
What are the key valuation metrics for AMRZ.SW stock?
Key metrics: current price CHF45.04, EPS CHF1.83, trailing PE 24.67, market cap CHF24,966,124,595, 50-day average CHF43.47 and 200-day average CHF41.20. These show modest premium to sector averages.
What does Meyka AI forecast for AMRZ.SW stock?
Meyka AI’s forecast model projects a yearly target of CHF48.24, an implied upside of 7.11% from CHF45.04. The monthly projection is CHF44.15. Forecasts are model-based and not guarantees.
What are the main risks to watch for AMRZ.SW stock after earnings?
Main risks include weaker-than-expected North American demand, margin contraction from rising inputs, and lower liquidity. Low relative volume could amplify price moves after the 17 Feb 2026 report.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)